Compugen Shareholders Approve All Proposals
Compugen to Present at Single Cell Genomics 2024 Conference
This Is Why Compugen Ltd.'s (NASDAQ:CGEN) CEO Compensation Looks Appropriate
Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Can Compugen (CGEN) Run Higher on Rising Earnings Estimates?
Truist Financial Maintains Compugen(CGEN.US) With Buy Rating
Truist Financial analyst Asthika Goonewardene maintains $Compugen(CGEN.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 30.3% and a total average return of -6.6%